Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × mogamulizumab × Dermatologic × Clear all

Phase

Status

Sponsor Class

OTHER 5 INDUSTRY 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

Interferon-alpha 6 Radiosurgery 4 Dacarbazine 4 aldesleukin 3 Radiotherapy 3 Gene Expression Profiling 3 Filgrastim 3 Etoposide 3 Cisplatin 3 encorafenib 2 binimetinib 2 Watchful Waiting 2 Vincristine 2 Vinblastine 2 Temozolomide 2 Methotrexate 2 Introns 2 Interferon alpha-2 2 Immunologic Techniques 2 Immunohistochemistry 2 Cyclophosphamide 2 Carboplatin 2 trametinib 1 tebentafusp 1 sulforaphane 1 romidepsin 1 perifosine 1 pembrolizumab 1 peginterferon alfa-2b 1 mogamulizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04128072 2024-04-05

MOGAT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡